Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer

doi:10.12998/wjcc.v10.i26.9264

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3270)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-9) series.

Item

Count

PDF

157

WORD

HTML

1691

Figures (1-2)

289

Tables (1-9)

215

Sum=2422

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

249

Download

599

Sum=848

Sep 16, 2022 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 16, 2022; 10(26): 9264-9275
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9264

Table 4 Influence of high-risk factors on primary liver cancer stratified by Barcelona stage

Factors	Criterion: Barcelona stage				Statistics	P value
Factors	A stage	B stage	C stage	D stage	Statistics	P value
Male (%)	36 (67.9)	42 (76.4)	51 (75.0)	87 (77.7)	1.90	0.594
Age (yr)	60.25 ± 11.57	65.15 ± 12.40	62.50 ± 11.28	60.80 ± 9.05	2.53	0.057
History of smoking (%)	14 (26.4)	20 (36.4)	23 (33.8)	40 (35.4)	1.58	0.664
History of drinking (%)	15 (28.3)	16 (29.1)	28 (41.2)	41 (36.3)	3.11	0.375
HBsAg (+) (%)	21 (39.6)^a	24 (43.6^a	31 (45.6)^a	78 (69.0)	18.90	< 0.001
HCV-Ag (+) (%)	4 (7.5)	4 (7.3)	3 (4.4)	6 (5.3)	0.79	0.852
Cirrhosis (%)	11 (20.8)^a	13 (23.6)^a	15 (22.1)^a	113 (100.0)	167.33	< 0.001
Non-alcoholic fatty liver (%)	14 (26.4)	18 (32.7)	15 (22.1)	20 (17.7)	5.08	0.166

^aCompared with “D”, P < 0.0083. HBsAg: Hepatitis B virus antigen; HCV: Hepatitis C virus.

Citation: Jiao HB, Wang W, Guo MN, Su YL, Pang DQ, Wang BL, Shi J, Wu JH. Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer. World J Clin Cases 2022; 10(26): 9264-9275
URL: https://www.wjgnet.com/2307-8960/full/v10/i26/9264.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i26.9264